Patrick E Duffy, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
14
14
12
N/A
0
16
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+18 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (14)
Showing 10 of 14 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Peter Aaby, Professor
Bandim Health Project
Shared therapeutic areas:
Paul Milligan, PhD
London School of Hygiene and Tropical Medicine
Shared therapeutic areas:
Sara A Healy, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Shared therapeutic areas:
Worked with same sponsors:
Brian Greenwood, MD
London School of Hygiene and Tropical Medicine
Shared therapeutic areas:
Peter Crompton, MD, MPH
National Institutes of Health (NIH)
Shared therapeutic areas:
Worked with same sponsors:
Kenneth H Brown, MD
University of California, Davis
Shared therapeutic areas:
Luc Van Bortel, MD, PhD
University Hospital, Ghent
Shared therapeutic areas:
Thomas B Nutman, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Shared therapeutic areas:
Worked with same sponsors:
Peter Aaby, DMSc
Bandim Health Project
Shared therapeutic areas:
Rick M Fairhurst, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (14)
Showing 14 of 14 trials
Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)
Malaria Transmission in Humans and Mosquitoes at the Area of Sabou, Burkina Faso
Plasmodium and Other Parasites in Pregnant Women and Children Around Margibi and Montserrado Counties, Liberia
Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Malaria Transmission Season in Healthy African Adult Women of Childbearing Potential in Mali
Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Protective Efficacy Against Natural Plasmodium Falcipa...
Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Mali
Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Mali
Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali
Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali
Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in Mali
Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali
All 14 trials loaded